Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 31, 2024 12:13 PM 3 min read

Microsoft 'In Major Growth Mode,' Not Slowing Down: 4 Analysts See Strong Azure Demand, AI Monetization Efforts

by Chris Katje Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Microsoft Corporation (NASDAQ:MSFT) analysts saw potential short-term setbacks with capacity constraints and weaker guidance than expected but were also looking at an exciting path for AI monetization ahead after first-quarter financial results.

The Microsoft Analysts: Bank of America analyst Brad Sills reiterated a Buy rating on Microsoft with a $510 price target.

Wedbush analyst Daniel Ives maintained an Outperform rating with a $550 price target.

Piper Sandler analyst Brent Bracelin maintained an Overweight rating with a $470 price target.

Goldman Sachs analyst Kash Rangan reiterated a Buy rating with a $500 price target.

Bank of America on MSFT: Strong growth of 34% for Microsoft's Azure beat an estimate of 33%, but the segment's future may be impacted by capacity constraints, Sills said in a new investor note.

Sills lowered financial estimates on the updated guidance, while he noted the outlook could be conservative from the company.

"We view second-quarter results as solid across the core Azure and Office growth businesses, though tempered by a softer second quarter outlook," Sills said.

The analyst said the lowered outlook is not "a demand issue" and the second half of the fiscal year could see a reacceleration.

Wedbush on MSFT: The first-quarter earnings report helped make Ives more bullish on the stock, with AI monetization the key for the future.

Ives said the Azure growth of 34% including a 12% positive impact from AI showed the "massive growth tailwinds" the company is seeing.

The analyst disagreed with shares trading down after the report on concerns for the second quarter outlook.

"The new Azure reporting standards have moved Street numbers all around and a slight decel is totally expected by many investors," Ives said. "We would be strong buyers of MSFT on any weakness."

Ives called the AI growth a "once in a 40-year tech transformation" and highlighted Microsoft's expected annual revenue run rate of $10 billion for AI in the next quarter.

"The bears will try to split hairs on any number but ultimately this is a tech stalwart in major growth mode … and we see no signs of slowing down."

Piper Sandler on MSFT: The quarterly results and outlook were a mixed bag for Bracelin, who is lowering earnings per share estimates and raising revenue estimates after the report.

"Our model reboot last week proved to be too conservative and are encouraged that demand continues to outstrip supply," Bracelin said.

The analyst saw a second-half acceleration in Azure growth.

Accounting recognition of Microsoft's OpenAI investment could temporarily drag earnings per share figures, the analyst added.

Goldman Sachs on MSFT: The narrative on Microsoft's financials could shift from higher CapEx concerns to the AI revenue opportunity, Rangan said in a new investor note.

The analyst saw lower Azure growth guidance and the negative impact to earnings from the OpenAI accounting issues as short-term items.

"We don't believe the value added by the OpenAI relationship is being fully reflected in the current valuation, despite the stock bearing the expense load," Rangan said.

The analyst said investors should shift their focus from cost concerns for the OpenAI investment to the revenue opportunities.

Microsoft's build-out of Azure could also help the company's roadmap on how to work through high costs for a new product cycle, the analyst added.

"We believe Microsoft is one of the most compelling investment opportunities in the technology industry and across sectors."

MSFT Price Action: Microsoft stock is down 5.51% to $408.72 on Thursday versus a 52-week trading range of $339.66 to $468.35. Microsoft stock is up over 10% year-to-date in 2024.

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorPrice TargetReiterationAnalyst RatingsTechTrading IdeasAIAI stocksartificial intelligenceAzureBank of AmericaBrad SillsBrent BracelinDaniel IvesExpert IdeasGoldman SachsKash RanganMicrosoft AzurePiper SandlerWedbush
MSFT Logo
MSFTMicrosoft Corp
$401.900.01%
Overview
MSFT Logo
MSFTMicrosoft Corp
$401.900.01%
Overview
Comments
Loading...